Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 169 clinical trials
Rehabilitation Needs After COVID-19 Hospital Treatment

The onset of Coronavirus Disease 2019 (COVID-19) in the first months of 2020 had a huge impact on Italian population and Healthcare System, with more than 150.000 total confirmed cases1.

respiratory infection
influenza
acute respiratory syndrome (sars)
coronavirus infection
dyspnea
  • 0 views
  • 05 Aug, 2020
Cardiovascular Consequences After COVID-19

The occurrence of cardiovascular complications in SARS-CoV-2 infections appears to be more frequent than in other viral respiratory infections, probably due to a singular pathophysiology of this coronavirus. The lack of characterization of cardiovascular damages linked to Covid-19 could have medium and long-term consequences on the prognosis of patients.

  • 0 views
  • 16 Feb, 2024
  • 1 location
Immune Response and Risk of Serious Infection to SARS-Cov2

To date, nearly 2 million people, including at least 100,000 in France, have been infected with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). This infection is very heterogeneous in nature, ranging from asymptomatic forms to acute respiratory distress syndrome patterns in 6.1% of cases, leading to an estimated overall mortality …

  • 0 views
  • 16 Feb, 2024
  • 1 location
COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus

Infection with the SARS-CoV-2 coronavirus strain is associated with severe morbidity and mortality estimated today from 2% to 4%. Elderly patients or patients with serious chronic conditions justifying hospitalization are particularly at risk.

respiratory infection
nosocomial infection
acute respiratory syndrome (sars)
influenza
coronavirus
  • 0 views
  • 16 Feb, 2024
  • 1 location
Immune Biomarkers of Outcome From COVID-19

A new virus to humans, first identified in December 2019, is causing a global pandemic with over 1 million infections and many thousands of deaths. The virus, SARS-CoV2, leads to coronavirus disease 2019 (COVID-19), which mainly affects the breathing system. Around 1 in every 5 people with COVID-19 have more …

heart disease
hypertension
acute respiratory syndrome (sars)
coronavirus infection
antibody test
  • 0 views
  • 16 Feb, 2024
  • 1 location
COVID-19: Study of INFLAmmasome and PLAtelets Functions

COVID-19 pandemic is a severe viral sepsis characterized by the occurrence of Acute respiratory distress syndrome (ARDS) whose pathophysiology is little described

respiratory distress
acute respiratory distress
inflammasome
viraemia
covid-19
  • 0 views
  • 05 Aug, 2020
Neuro-COVID-19: Neurological Complications of COVID-19

The prevalence and typical patterns of neurological complications in hospitalized COVID-19 patients admitted to the intensive care units of the University Hospital Zurich will be investigated. The impact of neurological complications among COVID-19 patients on mortality, functional outcome, and organizational outcomes will be analyzed.

  • 0 views
  • 05 Aug, 2020
Repeated Employee Testing for Understanding Our Recovery to Normal

The purpose of this research study is 1) to conduct a prospective longitudinal surveillance research trial, enrolling up to 200 CCHMC employees as they come back to work, and then following their clinical and laboratory parameters for up to 12 months; and 2) to support the ongoing development of diagnostic …

covid-19
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 16 Feb, 2024
  • 1 location
COVID-19: Respiratory and Sleep Follow-up

The current project is a prospective, multicentric cohort study aiming at a multidisciplinary assessment (pulmonary, cardiometabolic, sleep and mental health) of the consequences of infection by SARS-CoV-2, 3 months after the diagnosis in order to better characterize these complications. 400 patients with a positive diagnosis of SARS-CoV-2 will be included …

covid-19
acute respiratory syndrome (sars)
SARS
  • 0 views
  • 16 Feb, 2024
  • 4 locations
Prospective Natural History Study of Smoking Immune Cell Profiles Epigenetics and COVID-19

Background Early evidence in the COVID-19 pandemic suggests that smokers are at a higher risk of having severe effects or dying from the disease. Smoking causes changes in immune cells. Researchers think this may be the reason why smokers are more likely to have severe effects from COVID-19. Researchers want …

body mass index
covid-19
blood test
social interaction
  • 0 views
  • 05 Aug, 2020